Brand-name · GLP-1 receptor agonist (orforglipron)

Foundayo™ Tablets

Foundayo™ (orforglipron) is the only GLP-1 pill for weight loss that can be taken any time of day, with or without food or water restrictions. FDA-approved for chronic weight management in adults with obesity or overweight with a weight-related condition.

Starting at$199.99/mo

Check If I Qualify Read the FAQs

Form

Oral tablet

Frequency

Once daily

Drug class

GLP-1 receptor agonist (orforglipron)

Who is a candidate for this medication?

Adults 18+ who prefer an oral option over injections.
BMI 30+, or 27+ with a weight-related condition.
Able to take a daily medication consistently.

Who this medication is not for

Personal or family history of medullary thyroid cancer or MEN 2.
Pregnancy, planning pregnancy, or breastfeeding.
Prior serious hypersensitivity to GLP-1 agonists.

Dosage overview

Phase	Dose
Starter	Low starting dose, taken once daily.
Titration	Escalated monthly per physician guidance to target dose.

Side effects to know about

Common

· Nausea
· Diarrhea
· Constipation
· Decreased appetite

Serious (call your doctor)

· Pancreatitis
· Gallbladder problems
· Kidney injury

How your care is monitored

Monthly physician review during titration.
Quarterly follow-up once at maintenance dose.

Pricing

Foundayo™ Tablets starts at $199.99/mo. No insurance required. HSA/FSA eligible. Cancel anytime.

Common questions

Is Foundayo as effective as injections?

Trials show meaningful weight loss with orforglipron, but average results are typically lower than tirzepatide injections. Your physician can help you weigh trade-offs.